Antidepressants may also be helpful in managing urinary incontinence (unintentionally passing urine) and stress incontinence (passing urine when there’s pressure on the bladder from coughing, jumping, ...

The following is a summary of “Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy,” published in the January 2025 issue of ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

The FDA approves Vertex's non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

The FDA approves suzetrigine, a non-opioid pain medication, offering a safer alternative to opioids for pain management, ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid medication for treating moderate to severe acute pain in adults. Journavx, approved ...

Vertex Pharma has secured FDA approval for its non-opioid pain drug suzetrigine, becoming the first new class of pain ...

In recent weeks, reports have been circulating about severe reactions in people who've taken over-the-counter vitamin B6 supplements.